SUPPLY Newsletter
EBA is pleased to announce the inaugural edition of the SUPPLY Project Newsletter. Plasma and plasma-derived medicinal products play an[…]
EBA Position on EU Pharma Proposal
17 October 2023 General Position on the European Commission’s proposal for a reform of the EU pharmaceutical legislation The European[…]
Safety and protection of plasma donors: A scoping review and evidence gap map
Read full article in Vox Sanquinis Situated within the SUPPLY project, this current scoping review, published in Vox Sanguinis, systematically identifies[…]
Overview strategies for blood donor selection vCJD
Several recent publications on transfusion risk assessment of variant Creutzfeldt-Jakob disease (vCJD) have led to changes in donor selection criteria[…]
CoRe SoHO calls on European lawmakers to focus on resilience and strategic role of public sector
How to ensure sufficiency of substances of human origin (SoHO) while improving the protection and welfare of our donors? And[…]
CoRe SoHO statement on ENVI Committee amendments to SoHO regulation (May 2023)
Brussels, 22 May 2023 Dear Member of the ENVI Committee, We are writing to you on behalf of the Common[…]
EBA Whole Blood Webinar Presentations
On December 9th, the European Blood Alliance (EBA) presented the “Implementation of Whole Blood for Transfusion” webinar, supported by the[…]
EBA Book
EBA published in 2012 a book containing the EBA perspective on the Challenges and developments in the field of Blood[…]
EBA Statement on recent vCJD risk assessments and their impact on blood and plasma collection (October 2022)
Recent updates regarding variant Creutzfeldt-Jakob disease risk assessments and impact on blood and plasma collection in Europe The emergence of[…]
EBA Position on the European Commission proposal for a SoHO Regulation (September 2022)
GENERAL POSITION ON THE PROPOSAL OF THE EUROPEAN COMMISSION FOR A REGULATION ON STANDARDS OF QUALITY AND SAFETY FOR SUBSTANCES[…]